The Importance of Simulation and Modelling in Clinical Trial Design
Andreas Krause, Lead Scientist, Modelling and Simulation, Actelion, shares his insights with Pharma IQ at Innovation in Clinical Design, Analysis and Reporting. Krause discusses the innovative uses and applications of simulation and modelling in the clinical trials arena and the potential benefits of both disciplines going forward.
Have Your Say
Rate this feature and give us your feedback in the comments section below
TO READ THE FULL STORY
Please note: That all fields marked with an asterisk (*) are required.